M&A Deal Summary

Med Opportunity Partners Acquires Pfanstiehl

On April 1, 2013, private equity firm Med Opportunity Partners acquired life science company Pfanstiehl from Ferro

Acquisition Highlights
  • This is Med Opportunity Partners’ 1st transaction in the Life Science sector.
  • This is Med Opportunity Partners’ 2nd transaction in the United States.
  • This is Med Opportunity Partners’ 1st transaction in Illinois.

M&A Deal Summary

Date 2013-04-01
Target Pfanstiehl
Sector Life Science
Buyer(s) Med Opportunity Partners
Sellers(s) Ferro
Deal Type Divestiture

Target

Pfanstiehl

Waukegan, Illinois, United States
Pfanstiehl, Inc. is a provider of specialized products and services for niche pharmaceutical and biotechnological applications. Pfanstiehl develops and manufactures high-purity, low-endotoxin sugars utilized as injectable excipients and for cell culture media and protein stabilization as well as high-potency active pharmaceutical ingredients (APIs), including cytotoxic actives. Pfanstiehl was founded in 1919 and is based in Waukegan, Illinois.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Med Opportunity Partners

Greenwich, Connecticut, United States

Investor Investor


Category Private Equity Firm
Founded 2006
Size Small
Type Sector Focused
DESCRIPTION

Med Opportunity Partners LLC is a specialist private equity firm focuses on the healthcare sector. The Firm targets companies proven, growth-oriented companies with strong market positions and experienced management. For growth investments, the Firm looks to commit $5 to $20 million. For LBOs, Med looks to commit $10 to $40 million per transaction. Target transactions are generally valued between $20 and $200 million. Specific areas of interest include medical devices, pharmaceuticals, medical technology and specialty health care services. Med Opportunity Partners LLC was formed in 2006 and is based in Greenwich, Connecticut.


DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Illinois) 1 of 1
Country (United States) 2 of 2
Year (2013) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-10-22 Reliable Biopharmaceutical

St. Louis, Missouri, United States

Reliable Biopharmaceutical LLC is a manufacturer of small volume, high value advanced pharmaceutical and biochemical intermediates, primarily for the generic injectable pharmaceutical industry.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-03 Reliable Biopharmaceutical

St. Louis, Missouri, United States

Reliable Biopharmaceutical LLC is a manufacturer of small volume, high value advanced pharmaceutical and biochemical intermediates, primarily for the generic injectable pharmaceutical industry.

Sell -

Seller(S) 1

SELLER

Ferro

Mayfield Heights, Ohio, United States

Category Company
Founded 1919
Sector Chemicals
Revenue 959M USD (2020)
DESCRIPTION
Ferro's corporate headquarters in Mayfield Heights, Ohio.
Ferro's corporate headquarters in Mayfield Heights, Ohio.

Ferro is a global supplier of technology-based functional coatings and color solutions. Ferro supplies functional coatings for glass, metal, ceramic, and other substrates and color solutions in the form of specialty pigments and colorants for a broad range of industries and applications. Ferro products are sold into the building and construction, automotive, electronics, industrial products, household furnishings, and appliance markets. The Company's reportable segments include Functional Coatings and Color Solutions. Ferro was formed in 1919 and is based in Mayfield Heights, Ohio.


DEAL STATS #
Overall 2 of 4
Sector (Life Science) 1 of 1
Type (Divestiture) 2 of 4
State (Illinois) 1 of 1
Country (United States) 2 of 4
Year (2013) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-10-03 Ferro Corp - Fine Chemicals Business

United States

Ferro Corp - Fine Chemicals Business produces electrolytes used in the manufacture of lithium batteries, specialty solvents, and phosphines and also does contract manufacturing of fine chemicals. The business includes manufacturing facilities in Baton Rouge, Louisiana and Suzhou, China.

Sell $66M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-02 Vetriceramici

Casola Valsenio, Italy

Vetriceramici S.p.A. designs, develops, manufactures, and supplies special products for the ceramics industry. Vetriceramici produces fusion colored grains, technical grains, matte colored micro-grains, frits, double charge products, ceramic glazes, and inks for digital printing.

Buy €83M